<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02279186</url>
  </required_header>
  <id_info>
    <org_study_id>septemper 2014</org_study_id>
    <nct_id>NCT02279186</nct_id>
  </id_info>
  <brief_title>Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section</brief_title>
  <official_title>Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section ,A Randomized Clinical Trial .</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams Maternity Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams Maternity Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the efficacy and safety of tranexamic acid in the reducing the blood loss
      during and after elective LSCS will be investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To state the effectiveness clinically and laboratory and safety of tranexamic acid in
      reducing blood loss during and after the elective lower segment cesarean section.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of blood loss during cesarean section after placental delivery till end of the operation.</measure>
    <time_frame>during and 2hours post cesarean section</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1.Vital signs eg:blood pressure ,heart rate ,respiratory rate during first two post operative hours .</measure>
    <time_frame>up to 24hours postoperative</time_frame>
    <description>composite</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse affect of tranexamic acid on mother and neonate .</measure>
    <time_frame>first 24 hours</time_frame>
    <description>eg:drug allergy ,drug interaction ,thrombotic manifestation and the number of participant .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 hours post operative haemoglobin and haematocrit .</measure>
    <time_frame>after 24 hours.</time_frame>
    <description>composite</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>receiving tranexamic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>does not receive tranexamic acid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid</intervention_name>
    <description>Intravenous Injection</description>
    <arm_group_label>group A</arm_group_label>
    <other_name>in 200 ml saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  - Women undergoing caesarean delivery for various elective indications.

          -  Full term primiparas / multiparas.

          -  Singleton pregnancy being delivered by LSCS.

        Exclusion Criteria:

          -  - Medical problems involving the heart, liver, kidney and brain .

          -  Blood disorders.

          -  Allergy to tranexamic acid.

          -  History of thromboembolic disorders, abnormal placentation, severe pre-eclampsia,
             uterine anomalies and pathology.

          -  Multiple pregnancy, macrosomia.

          -  Polyhydromnios .

          -  Patients requiring blood transfusion due to anemia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr Abdelaziz, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams Maternity Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud Shalby, MBBCH</last_name>
    <phone>01121117275</phone>
    <phone_ext>202</phone_ext>
    <email>dr_mahmoud.mostafa@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amr Abdelaziz, M.D</last_name>
    <phone>01001783383</phone>
    <phone_ext>202</phone_ext>
    <email>dr_AmrAziz@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ain Shams Maternity Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>02</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nashwa AlSaied, M.D</last_name>
      <phone>01005369353</phone>
      <phone_ext>202</phone_ext>
    </contact>
    <contact_backup>
      <last_name>Amr Abdelaziz, M.D</last_name>
      <phone>01001783383</phone>
      <phone_ext>202</phone_ext>
      <email>dr_AmrAziz@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2014</study_first_submitted>
  <study_first_submitted_qc>October 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2014</study_first_posted>
  <last_update_submitted>November 1, 2014</last_update_submitted>
  <last_update_submitted_qc>November 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams Maternity Hospital</investigator_affiliation>
    <investigator_full_name>Mahmoud Mostafa Abdellah Mostafa</investigator_full_name>
    <investigator_title>Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section ,A Randomized Clinical Trial.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

